OKLAHOMA CITY, OKLA. – As of Jan. 1, Drew Smith & Associates has partnered with INSURICA, furthering its experience and expertise in the healthcare sector.
“Drew Smith and his team are a huge contribution to the healthcare practice,” Vice President and Healthcare Practice Leader Phillip Smith said. “Whatever a physician needs, Drew handles it. He truly has a unique skill set.”
Founded in 2004, Drew Smith and & Associates represents physicians, providing medical malpractice insurance and small group insurance plans.
“This partnership changes the dynamic,” Drew Smith said. “Having your own shop is a lot of fun, and a lot of work but you also get to a certain point where you reach a sense of comfort. Moving to INSURICA brings you to another level and presents a wonderful opportunity to grow given the available resources.”
Drew brings a talented team, consisting of Leisa Hall and Cassie Williams, who all add valuable expertise and experience to INSURICA’s Healthcare Practice, Phillip Smith said.
Placing over $1 billion in annual premiums for our clients, INSURICA is among the 50 largest insurance brokers in the United States and is currently the 42nd largest privately-held independent agency in the country.
Headquartered in Oklahoma City, INSURICA employs more than 700 colleagues in 35+ offices located throughout 11 states.
About the Author
Share This Story
Related Blogs
Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now
When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.
The New Era of Mental Health Parity Enforcement in 2026
Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.
The 2026 Specialty Drug Surge: What Employers Need to Prepare For
Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.